Agios Pharmaceuticals, Inc. (AGIO)
Healthcare
Biotechnology
30.00 $
-8.3%
vs. previous close
Closing price · As of: 31. Jul 2026
Agios Pharmaceuticals, Inc. (AGIO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -57 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -62 | -72 | -100 | -73 | -84 | -133 | -111 | -77 | -88 | -96 | -119 | -57 | -361 | |
| 1.6 | 1.4 | 1.3 | 1.6 | 1.3 | 1.4 | 1.3 | 1.3 | 1.4 | 1.3 | 1.4 | 1.4 | 5.4 | |
| 9.1 | 14 | 9.2 | 12 | 11 | 11 | 11 | 15 | 12 | 14 | 16 | 16 | 58 | |
| 31 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -2.7 | 5.6 | -29 | 10 | 45 | -46 | -37 | 8.3 | -0.2 | -4.6 | -39 | -1.0 | -45 | |
| 0.4 | 0.2 | 0.1 | 0.2 | 0.4 | 1.0 | 0.8 | 0.9 | 1.6 | 1.1 | 0.8 | 1.2 | 4.7 | |
| 39 | 96 | 125 | 37 | 251 | -49 | 113 | 79 | 96 | 90 | 141 | 40 | 367 | |
| 1.9 | 0.8 | 5.9 | 1.1 | 2.6 | 4.8 | 1.6 | 0.1 | 4.4 | 2.6 | 2.1 | 3.1 | 12 | |
| -20 | 24 | 31 | -34 | 169 | -177 | 2.7 | 1.9 | 12 | -3.6 | 24 | -14 | 19 | |
| -62 | -73 | -100 | -73 | -85 | -134 | -112 | -78 | -90 | -97 | -120 | -59 | -365 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.